This week has seen the launch of new and lower-priced biosimilars to AbbVie’s Humira (adalimumab), many ... Additionally, the Hyrimoz formulation is a citrate-free high concentration, aiming ...
Yesterday, Amgen announced that it would launch the U.S.’s first marketed Humira-referenced biosimilar, Amjevita (adalimumab-atto), at two different list prices: $3,288 and $1,557 per 40 mg pen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback